Long-term safety of fluticasone furoate nasal spray (FFNS) 110 μg once-daily in adults and adolescents with perennial allergic rhinitis

被引：0
|
作者：
Rosenblut, A.
Bardin, P.
Fokkens, W.
Faris, M.
Wu, W.
Caldwell, M.
Rinia, B.
机构：
[1] Clin Arauco, Jefe Unidad Otorrinolaringol, Santiago, Chile
[2] Monash Med Ctr, Dept Resp & Sleep Med, Clayton, Vic 3168, Australia
[3] Univ Amsterdam, Acad Med Ctr, Div Neurozintuigspecialsmen, NL-1105 AZ Amsterdam, Netherlands
[4] GlaxoSmithKline Inc, Greenford, Middx, England
[5] GlaxoSmithKline Inc, Resp MDC, Res Triangle Pk, NC USA
来源：
ALLERGY | 2007年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [31] Fluticasone Furoate Nasal Spray is Effective in Perennial Allergic Rhinitis Irrespective of Severity
    Miller, S. D.
    Lim, J.
    Wu, W.
    Philpot, E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S134 - S134
  • [32] Efficacy and safety of long-term treatment of perennial allergic rhinitis with mometasone furoate nasal spray in japanese subjects
    Ishikawa, T.
    Soh, N.
    Oda, T.
    Jensen, P.
    ALLERGY, 2008, 63 : 362 - 362
  • [33] Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen
    Fokkens, W. J.
    Jogi, R.
    Reinartz, S.
    Sidorenko, I.
    Sitkauskiene, B.
    van Oene, C.
    Faris, M. A.
    Ellsworth, A.
    Caldwell, M. F.
    ALLERGY, 2007, 62 (09) : 1078 - 1084
  • [34] ONCE-DAILY INTRANASAL FLUTICASONE PROPIONATE IS EFFECTIVE FOR PERENNIAL ALLERGIC RHINITIS
    BANOV, CH
    WOEHLER, TR
    LAFORCE, CF
    PEARLMAN, DS
    BLUMENTHAL, MN
    MORGAN, WF
    FRAZER, H
    SOUTHERN, DL
    GOLD, B
    FIELD, E
    KRAL, K
    ROGENES, PR
    ANNALS OF ALLERGY, 1994, 73 (03): : 240 - 246
  • [35] Efficacy and safety of once-daily ciclesonide nasal spray in children with allergic rhinitis
    Berger, W. E.
    Nayak, A.
    Lanier, B. Q.
    Kaiser, H. B.
    LaForce, C.
    Darken, P.
    Hall, N.
    Wingertzahn, M. A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A4 - A5
  • [36] Efficacy of a novel enhanced-affinity glucocorticoid on ocular symptoms, fluticasone furoate nasal spray (FFNS) 110 μg once-daily, in grass pollen-sensitive patients
    Sidorenko, I.
    Sitkauskiene, B.
    Jogi, R.
    Fokkens, W.
    van Tongeren, J.
    Faris, M.
    Ellsworth, A.
    Caldwell, M.
    ALLERGY, 2007, 62 : 134 - 135
  • [37] Once-daily mometasone furoate nasal spray reduces ocular symptoms associated with seasonal allergic rhinitis
    Prenner, B.
    Shekar, T.
    Teper, A.
    ALLERGY, 2008, 63 : 366 - 366
  • [38] ONCE-DAILY VERSUS TWICE-DAILY FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY FOR SEASONAL ALLERGIC RHINITIS
    DOCKHORN, RJ
    PAULL, BR
    MELTZER, EO
    VANAS, A
    WEAKLEY, S
    WOEHLER, TR
    KRAL, KM
    ROGENES, PR
    AMERICAN JOURNAL OF RHINOLOGY, 1993, 7 (02): : 77 - 83
  • [39] Effect on nasal eosinophilia by once-daily, intranasal fluticasone furoate in an irritant rhinitis population
    Philpot, E.
    Toler, W.
    Wu, W.
    Lee, L.
    ALLERGY, 2010, 65 : 280 - 281
  • [40] Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study
    LaForce, Craig
    Journeay, Glen E.
    Miller, S. David
    Silvey, Mary Jane
    Wu, Wei
    Lee, Laurie A.
    Chylack, Leo T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (01) : 45 - 50
12345